Entrada Therapeutics, Inc. (TRDA) Ownership

$12.49

south_east
-$0.88 (-6.58%)
Day's range
$12.35
Day's range
$13.67

Entrada Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 11/14/2024 4.87 M $77.76 M   0.00% 11.98%
MPM ASSET MANAGEMENT LLC 11/13/2024 4.43 M $70.72 M   0.00% 10.89%
5AM VENTURE MANAGEMENT, LLC 11/14/2024 4.41 M $70.45 M   0.00% 10.85%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 3.05 M $48.73 M   -2.71% 7.51%
BLACKROCK FUNDING, INC. /DE 11/13/2024 1.82 M $29.13 M   100.00% 4.49%
FMR LLC 11/13/2024 1.74 M $27.86 M   -4.68% 4.29%
JANUS HENDERSON GROUP PLC 11/14/2024 1.71 M $27.36 M   10.45% 4.21%
VANGUARD GROUP INC 11/13/2024 1.22 M $19.55 M   8.28% 3.01%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2024 1.03 M $16.45 M   -0.44% 2.53%
STEPSTONE GROUP LP 11/12/2024 761,277 $12.17 B   0.00% 1.87%
TCG CROSSOVER MANAGEMENT, LLC 11/14/2024 584,955 $9.35 M   0.00% 1.44%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 576,451 $9.21 M   8.78% 1.42%
STATE STREET CORP 11/14/2024 469,601 $7.50 M   5.48% 1.16%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/14/2024 201,803 $3.22 M   50.33% 0.50%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 185,984 $2.97 M   14.56% 0.46%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/08/2024 138,605 $2.21 M   132.36% 0.34%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 129,866 $2.08 M   5.70% 0.32%
MILLENNIUM MANAGEMENT LLC 11/14/2024 110,943 $1.77 M   -24.69% 0.27%
MOORE CAPITAL MANAGEMENT, LP 11/14/2024 105,000 $1.68 M   0.00% 0.26%
BANK OF NEW YORK MELLON CORP 11/12/2024 104,967 $1.68 M   -16.32% 0.26%
MARSHALL WACE, LLP 11/14/2024 100,106 $1.60 M   51.81% 0.25%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/14/2024 99,697 $1.59 M   596.84% 0.25%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 95,408 $1.53 M   100.00% 0.23%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 93,800 $1.50 M   110.31% 0.23%
MORGAN STANLEY 11/14/2024 93,266 $1.49 M   90.14% 0.23%
CITADEL ADVISORS LLC 11/14/2024 88,224 $1.41 M   -32.37% 0.22%
GOLDMAN SACHS GROUP INC 11/14/2024 84,466 $1.35 M   153.64% 0.21%
FIRST TRUST ADVISORS LP 11/13/2024 81,549 $1.30 M   100.00% 0.20%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 11/12/2024 69,394 $1.11 M   100.00% 0.17%
ACADIAN ASSET MANAGEMENT LLC 11/12/2024 65,523 $1.04 M   390.18% 0.16%
CORTON CAPITAL INC. 11/14/2024 57,849 $924,427   5.23% 0.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2024 57,331 $916,149   100.00% 0.14%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/13/2024 56,855 $908,543   -0.43% 0.14%
AMERICAN CENTURY COMPANIES INC 11/12/2024 50,725 $810,586   -86.82% 0.12%
NAN FUNG GROUP HOLDINGS LTD 11/13/2024 49,082 $784,330   0.00% 0.12%
LPL FINANCIAL LLC 11/08/2024 48,844 $780,527   100.00% 0.12%
TD ASSET MANAGEMENT INC 11/01/2024 47,788 $786,113   -32.98% 0.12%
BARCLAYS PLC 11/19/2024 45,110 $720,000   210.57% 0.11%
SQUAREPOINT OPS LLC 11/14/2024 41,568 $664,257   60.19% 0.10%
XTX TOPCO LTD 11/14/2024 39,670 $633,927   100.00% 0.10%
AQR CAPITAL MANAGEMENT LLC 11/14/2024 39,468 $630,699   100.00% 0.10%
LAZARD ASSET MANAGEMENT LLC 11/14/2024 39,441 $630,000   1,179.72% 0.10%
STRS OHIO 11/01/2024 38,500 $615,230   34.62% 0.09%
AMERIPRISE FINANCIAL INC 11/14/2024 38,107 $608,950   181.29% 0.09%
MARTINGALE ASSET MANAGEMENT L P 11/14/2024 37,923 $606,010   36.92% 0.09%
GSA CAPITAL PARTNERS LLP 11/05/2024 36,577 $585,000   71.78% 0.09%
RHUMBLINE ADVISERS 11/12/2024 36,298 $580,033   -1.74% 0.09%
BANK OF AMERICA CORP /DE/ 11/14/2024 34,061 $544,294   17.74% 0.08%
LOS ANGELES CAPITAL MANAGEMENT LLC 11/04/2024 33,932 $542,233   100.00% 0.08%
SWISS NATIONAL BANK 11/07/2024 32,800 $524,144   0.00% 0.08%

Entrada Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of TRDA shares?

During the previous two years, 102 institutional investors and hedge funds held shares of Entrada Therapeutics, Inc.. The most heavily invested institutionals were:

BAKER BROS. ADVISORS LP: 4.87 M

MPM ASSET MANAGEMENT LLC: 4.43 M

5AM Venture Management, LLC: 4.41 M

PRICE T ROWE ASSOCIATES INC /MD/: 3.05 M

BlackRock Funding, Inc. /DE: 1.82 M

FMR LLC: 1.74 M

What percentage of Entrada Therapeutics, Inc. stock is owned by institutional investors?

74.09% of Entrada Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at TRDA ?

Institutional investors have bought a total of 31.51 M shares in the last 24 months. This purchase volume represents approximately $393.55 M in transactions.